Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Celcuity Inc. - Common Stock
(NQ:
CELC
)
112.63
-0.30 (-0.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
501,392
Open
109.20
Bid (Size)
111.00 (100)
Ask (Size)
114.50 (900)
Prev. Close
112.93
Today's Range
109.20 - 114.65
52wk Range
7.575 - 120.31
Shares Outstanding
46,271,259
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Celcuity Stock Popped Today
↗
March 26, 2026
The cancer-focused biotech published its final set of figures for 2025.
Via
The Motley Fool
Celcuity Inc. (NASDAQ:CELC) Reports Q4 Earnings Beat and Key FDA Priority Review for Gedatolisib
↗
March 25, 2026
Via
Chartmill
Topics
Earnings
Performance
YTD
+12.0%
+12.0%
1 Month
+4.0%
+4.0%
3 Month
+12.9%
+12.9%
6 Month
+149.1%
+149.1%
1 Year
+1112.4%
+1112.4%
More News
Read More
The Great Rotation: Russell 2000 Outshines Mega-Caps as Domestic Small-Caps Take the Reins in 2026
March 24, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6?
↗
March 20, 2026
Via
The Motley Fool
Celcuity Stock Near All-Time Highs — And This Major Biotech Investor Is Still Jumping In
↗
December 02, 2025
Via
The Motley Fool
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug
↗
March 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Apis Capital Trims Holdings of Celcuity Stock, According to Recent SEC Filing
↗
March 10, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Investment Manager Closes Position in GEO Stock, Sells $17.6 Million Worth of Shares, According to Recent SEC Filing
↗
March 10, 2026
Via
The Motley Fool
Topics
Immigration
Regulatory Compliance
Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing
↗
March 09, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing
↗
March 06, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing
↗
March 05, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing
↗
March 04, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
The Great Rotation of 2026: Why Small-Cap 'Underdogs' are Finally Outpacing the Tech Titans
March 04, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Apis Capital Expands Garrett Motion Stake as Hybrid Demand Extends the Combustion Cycle
↗
February 26, 2026
Via
The Motley Fool
Topics
Economy
Emissions
Regulatory Compliance
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million
↗
February 22, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position
↗
February 22, 2026
Via
The Motley Fool
Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction
↗
February 22, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges
↗
February 22, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Soleus Adds a Significant Number of Celcuity Shares
↗
February 13, 2026
Via
The Motley Fool
Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump
↗
February 06, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
January 08, 2026
From
Equity Insider
Via
GlobeNewswire
The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens
January 02, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
3 Stocks You’ll Wish You Bought Before 2026
↗
December 03, 2025
Via
MarketBeat
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results
↗
November 28, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results
↗
November 27, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Frequently Asked Questions
Is Celcuity Inc. - Common Stock publicly traded?
Yes, Celcuity Inc. - Common Stock is publicly traded.
What exchange does Celcuity Inc. - Common Stock trade on?
Celcuity Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Celcuity Inc. - Common Stock?
The ticker symbol for Celcuity Inc. - Common Stock is CELC on the Nasdaq Stock Market
What is the current price of Celcuity Inc. - Common Stock?
The current price of Celcuity Inc. - Common Stock is 112.63
When was Celcuity Inc. - Common Stock last traded?
The last trade of Celcuity Inc. - Common Stock was at 04/02/26 04:00 PM ET
What is the market capitalization of Celcuity Inc. - Common Stock?
The market capitalization of Celcuity Inc. - Common Stock is 5.21B
How many shares of Celcuity Inc. - Common Stock are outstanding?
Celcuity Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
